Questions?
Contact us
We’d love to tell you more about this news.
IGS GeboJagema expects a revenue of 38 to 40 million this year. The Dutch company that operates mostly in the healthcare industry has been largely unaffected by the pandemic and continues to grow as projected. “We’re seeing all major developments go ahead as planned”, CEO Peter Mertens explains. “The healthcare industry is focused on 2030, not on tomorrow.”
IGS delivers injection moulds to manufacturers of medical devices such as insulin pens, inhalers and contact lenses. These are relatively new markets for the company, as Mertens knows. “In 2006, we mainly built moulds for mobile phones, printers and the automotive industry. We decided to change course and focus on the medical sector from that point on, fully committing to innovation, automation and high precision.”
Over the past decade, the company hit a growth spurt as it established a firm position in the healthcare sector. Turnover grew from 10 million in 2010 to an expected 38 to 40 million in 2020. “The pharmaceutical industry is built on trust,” Mertens explains. “The market is composed of a small number of major players. We are very proud that we’ve been able to gain a foothold in the industry.”
Automation
Automation in the Eindhoven factory played a key role in the company’s growth. While IGS nearly quadrupled its revenue over the past decade, the number of employees only increased from 70 to 100. According to Mertens, automation increases both efficiency and quality, while also making the lack of skilled workmen in the labour market less of a problem. “The old-fashioned workman is slowly becoming obsolete,” says the CEO, who started his career as a grinder in the workshop before working his way up in the organisation. “More and more, manual activities are being replaced with the controlling and programming of machines.” The factory operates twenty-four hours a day, seven days a week, though the staff is only present during the day. Mertens: “In the evening, we switch off the lights and everyone goes home.”
Dutch mold maker record breaking revenue (press release)
